S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
OTCMKTS:SEOVF

Sernova (SEOVF) Stock Forecast, Price & News

$1.20
+0.12 (+10.65%)
(As of 05/13/2022 03:39 PM ET)
Add
Compare
Today's Range
$1.08
$1.20
50-Day Range
$1.07
$1.23
52-Week Range
$0.92
$1.76
Volume
156,700 shs
Average Volume
51,138 shs
Market Capitalization
$313.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.17
30 days | 90 days | 365 days | Advanced Chart
Receive SEOVF News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

Sernova logo

About Sernova

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of various serious chronic diseases, such as diabetes, hemophilia, and thyroid disease. Sernova Corp. has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected therapeutic cells; and a research agreement with the University of Miami to advance the development of Cell Pouch cell therapy platform. The company was incorporated in 1998 and is headquartered in London, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:SEOVF
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.09 per share

Profitability

Net Income
$-5.54 million
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$313.78 million
Optionable
Not Optionable

Company Calendar

Last Earnings
3/29/2022
Today
5/15/2022
Fiscal Year End
10/31/2022

MarketRank

Overall MarketRank

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Sernova (OTCMKTS:SEOVF) Frequently Asked Questions

How were Sernova's earnings last quarter?

Sernova Corp. (OTCMKTS:SEOVF) released its quarterly earnings results on Tuesday, March, 29th. The company reported ($0.02) earnings per share for the quarter.
View Sernova's earnings history
.

Who are Sernova's key executives?
Sernova's management team includes the following people:
  • Mr. Frank A. Holler MBA, Exec. Chairman (Age 65, Pay $52.61k)
  • Dr. Philip M. Toleikis B.A., M.Sc., Ph.D., Pres, CEO & Director
  • Mr. David Swetlow C.A, C.A., CPA, Chief Financial Officer
  • Mr. Douglas Maret, Chief Science Officer
  • Mr. Christopher Barnes, VP of Investor Relations
What is Sernova's stock symbol?

Sernova trades on the OTCMKTS under the ticker symbol "SEOVF."

How do I buy shares of Sernova?

Shares of SEOVF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sernova's stock price today?

One share of SEOVF stock can currently be purchased for approximately $1.20.

How much money does Sernova make?

Sernova has a market capitalization of $313.78 million. The company earns $-5.54 million in net income (profit) each year or ($0.05) on an earnings per share basis.

What is Sernova's official website?

The official website for Sernova is www.sernova.com.

How can I contact Sernova?

Sernova's mailing address is 700 COLLIP CIRCLE SUITE 114, LONDON A6, N6G 4X8. The company can be reached via phone at (519) 858-5184, via email at [email protected], or via fax at 519-858-5184.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.